PACAP-1-38
Cat.No:IP3120 Solarbio
CAS:137061-48-4
Molecular Formula:C203H331N63O53S
Molecular Weight:4534.26
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥96%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Others > PACAP-1-38CAS:137061-48-4
Molecular Formula:C203H331N63O53S
Molecular Weight:4534.26
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥96%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 137061-48-4 |
| Name | PACAP-1-38 |
| Molecular Formula | C203H331N63O53S |
| Molecular Weight | 4534.26 |
| Solubility | Soluble in Water |
| Purity | ≥96% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| MDL | MFCD00081800 |
| SMILES | --- |
| Target Point | PACAP receptor |
| Passage | Others |
| Background | H-Gly-Gly-Pro-OH is a polypeptide consisting of 3 amino acids. |
| Biological Activity | PACAP (1-38), human, ovine, rat is a neuropeptide with 38 amino acid residues. PACAP (1-38) binds to PACAP type I receptor, PACAP type II receptor VIP1, and PACAP type II receptor VIP2 with IC50s of 4 nM, 2 nM, and 1 nM, respectively.[1-4] |
| IC50 | 4nM(PACAP type I receptor);2nM(PACAP type II receptor VIP1);1nM(PACAP type II receptor VIP2)[1] |
| Data Literature Source | [1]. Gourlet P,et al. Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors. Eur J Pharmacol. 1995 Dec 4;287(1):7-11. [2]. Yamaguchi N. Pituitary adenylate cyclase activating polypeptide enhances glucose-evoked insulin secretion in the canine pancreas in vivo. JOP. 2001 Sep;2(5):306-16. [3]. Lindén A,et al. Inhibition of bronchoconstriction by pituitary adenylate cyclase activating polypeptide (PACAP 1-27) in guinea-pigs in vivo. Br J Pharmacol. 1995 Jul;115(6):913-6. [4]. Werling D,et al. Passage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP (1-38) in Rodents. Int J Mol Sci. 2017 Mar 21;18(3). pii: E675. |
| Unit | Bottle |
| Specification | 1mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download